Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose enoximone pilot study in intubated acute exacerbation COPD
NL-OMON49504Phase 4Active, not recruiting
- Sponsor
- Rijnstate
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of enoximone in chronic obstructive pulmonary disease (COPD), sponsored by Rijnstate. Primary endpoint: Auto-PEEP. Started May 2020; status: active, not recruiting.
02
Drugs
enoximone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NL-OMON49504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49504.